Enrox Flavour (30 kg)

10 x 10 pc

Tablet

Active substance

Enrofloxacin : 150 mg

ATC code

QJ01MA90 Enrofloxacin

QJ01MA Fluoroquinolones

QJ01M Quinolone and quinoxaline antibacterials

QJ01 Antibacterials for systemic use

QJ Antiinfectives for systemic use

Species

Dogs.

Indications

The veterinary medicinal product is for use in dogs for the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

Dose to be administered and administration route

Oral use.

Do not exceed the recommended dose. The dosage rate of enrofloxacin is 5 mg/kg given orally once daily or as a divided dose twice daily for 5 to 10 days.

The duration of treatment in dogs may be extended depending on the clinical response and the judgement of the responsible veterinary surgeon.

To ensure a correct dosage, body weight should be determined as accurately as possible.

The daily dose is achieved as follows:

Large dogs: one tablet per 30 kg body weight.

Adverse reactions

Dogs:

Very rare

(<1 animal / 10,000 animals treated, including isolated reports):

Anorexia

Vomiting

Undetermined frequency

(cannot be estimated from the available data)

Joint cartilage disorder¹

¹During the period of rapid growth, articular cartilage development may be affected.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.